Learn More
Because primary immunodeficiencies (PID) are rare diseases, transnational studies are essential to maximize the scientific outcome and lead to improved diagnosis and therapy. Immunologists in Europe have united to determine the prevalence of PID in Europe and to establish and evaluate harmonized guidelines for the diagnosis and treatment of PID as well as(More)
UNLABELLED Primary immunodeficiencies (PIDs) belong to the group of rare diseases. The European Society for Immunodeficiencies (ESID), is establishing an innovative European patient and research database network for continuous long-term documentation of patients, in order to improve the diagnosis, classification, prognosis and therapy of PIDs. The ESID(More)
101 regular class and learning disabled students were administered three subtests of the Comprehensive Test of Basic Skills for which all correct answers had been identified in the students' test booklet. Analysis of the completed separate answer sheets indicated that learning disabled students answered fewer total items than their nondisabled peers but did(More)
  • 1